T cells are central to the body's defense ... anti-tumor immunity is an emerging area in cancer therapy, systemically inhibiting Tregs can cause severe autoimmune reactions. This challenge has ...
AstraZeneca has exercised an option to license a cell therapy from Quell Therapeutics, resulting in a $10m milestone payment ...
UK start-up Quell Therapeutics has secured a partnership with AstraZeneca focused on cell therapies for autoimmune diseases, with an $85 million upfront payment and which could be worth up to $2 ...
It highlights the strong commitment and rapid integration of our respective research teams as well as providing important early validation of our novel CAR-Treg cell therapy approach to autoimmune ...
A University professor has found a new way to treat cancer using different cell compounds, like the NR0B2 protein.
While the human body’s immune system is generally able to defend against harmful germs, diseases like cancer are trickier to ...
Regenerative medicine holds the extraordinary promise that future patients in need of new cells, tissues or organs will no ...
Researchers collaborated on a novel, highly specific strategy to treat type 1 diabetes using a tagged beta cell transplant in ...